AppLovin: A 1% Revenue Miss, a 19% Stock Drop, and the Selloff That Went Too Far (Upgrade)

I've been puzzled by what happened to AppLovin this week. The company missed Q2 revenue by roughly 1% and guided Q3 about 0.6% below Wall Street's midpoint. Revenue grew 53% year-over-year. Earnings beat by a cent. And the stock dropped nearly 19% on the report, extending a decline of roughly 50% year-to-date and touching levels not seen in over a year.

What more do investors want?

The market has arguably baked in a doomsday narrative about AppLovin's growth trajectory, even though revenue is still surging at a triple-digit-adjacent pace, and the balance sheet sits on $3 billion in cash. That disconnect is where the opportunity starts.

The Miss Was a Timing Glitch, Not a Thesis Break

Let's be precise about what went wrong. AppLovin reported Q2 revenue of $1.92 billion against consensus estimates in the $1.94 to $1.95 billion range — a miss of about $20 to $30 million on nearly $2 billion of top line.

Q3 revenue guidance of $2.07 billion came in 0.6% below analysts’ estimates, as reported. That is not a broken growth engine. That is a company that delivered five quarters of sequential model uplifts and then hit a quarter where the machine learning improvements were a bit slower than consensus assumed.

The earnings side tells the same story. Diluted EPS of $3.76 edged past the $3.75 consensus. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization — a rough cash-earnings proxy that strips out non-operating costs) reached $1.61 billion with an 84% margin. These are not the numbers of a company whose competitive position is deteriorating.

The Valuation Gap Is the Real Story

AppLovin's market cap has been slashed from its recent peak above $160 billion to roughly $113 billion at current levels. The trailing P/E sits at 25.7x. The forward P/E — which prices in expected future earnings — is approximately 40.7x. The PEG ratio (which divides the forward P/E by the revenue growth rate to show whether valuation is justified by growth) is 0.31.

A PEG of 0.31 means the market is paying just 0.31 dollars of multiple for every dollar of growth rate. For context, the S&P 500 averages a PEG near 1.5 to 2.0. AppLovin is growing revenue at 60.6% year-over-year and trading as if it's growing at roughly 130%. That's not to say the stock is cheap in absolute terms — a 40x forward multiple is still elevated. But the forward P/E has been compressed from well above 50x levels earlier in the run-up, and the gap between that compression and the actual growth rate has turned this into a genuine valuation disconnect.

EV/EBITDA at 21x is rich compared to Meta at 13.6x, but AppLovin's revenue growth (60.6% vs. Meta's single-digit growth) and EBITDA margin (84%) make the comparison one-dimensional. AppLovin is a different business: an AI-powered ad discovery platform, not a social media network monetizing user attention. The higher multiple reflects faster growth, not irrationality.

The Moat Survives the Selloff

Before calling contrarian on a 50% YTD decline, I need to verify the competitive moat hasn't cracked under the pressure. Here's what's intact.

The platform generates revenue whether AppLovin wins the ad auction (20–30% take rate) or loses to a competitor like Meta (5% fee on the transaction).

The real competitive question is whether Meta or Google could use their own AI advances to disintermediate AppLovin in mobile ad discovery. That's easier said than done. But it competes on a different axis: performance optimization for return on ad spend, not social graph reach. The e-commerce expansion is underway. The moat hasn't cracked.

Price Action: Selling Exhaustion, Not Just a Falling Knife

AppLovin's RSI sits at 29.5, well below the 30 threshold that marks oversold territory. The stock is down 16% over the past five days and 35% over the past 20 trading sessions. It trades roughly 30% below its 50-day moving average ($483) and more than 30% below its 200-day moving average ($516). The 1-day volatility hit 25.8%, indicating a violent, compressed selloff rather than a slow bleed.

This is not a gradual loss of conviction. This is the kind of sharp, volume-driven capitulation that often marks selling exhaustion. The MACD is deeply negative at -26.2, confirming the momentum breakdown, but RSI at sub-30 levels after a 50% decline from highs is the kind of setup where contrarian entries find their footing.

That said, I'm not telling anyone to catch a falling knife blindly. The AInvest aggregate signal still labels AppLovin a Buy, with a fundamental rating of 6.53 and a composite analysis score of 5.94. But the price action has not yet confirmed a bear trap — the pattern where a stock breaks below a key level on heavy volume, triggers stop losses, then reverses sharply. That confirmation is what separates "add on weakness" from "wait and watch."

The Counterpoint Worth Respecting

The bear case has three legs: growth deceleration from 70%+ to the mid-40s range in Q3 guidance, rising R&D and compute costs, and the risk that the consumer ad expansion into non-gaming categories proves harder than the gaming core. The growth deceleration narrative gains real traction. These are legitimate concerns that would justify a more patient stance.

The Verdict: Upgrade to Buy, but Don't Chase

AppLovin's Q2 miss was a timing issue, not a structural problem. The company is still growing revenue at 53% with an 84% EBITDA margin. The PEG ratio of 0.31 signals that the market's panic has disconnected valuation from the actual growth rate. The moat — MAX platform lock-in and AXON's data advantage — remains intact.

My view is an upgrade to Buy. The risk/reward at $339, down 50% YTD from the $745 high, is compelling for a company with this growth profile. But the entry discipline matters. The RSI is oversold, which suggests a bounce is likely, but the full bear-trap confirmation hasn't arrived yet. I would look to add positions on evidence of selling exhaustion stabilizing — a day where the stock holds above the $330–$340 range on lighter volume, signaling that the panic selling has run out of steam.

I would reassess the thesis if Q3 revenue comes in below $2.05 billion, if EBITDA margins fall below 80%, or if the consumer expansion shows zero traction in the second half. Until then, the market's reaction to a 1% revenue miss looks like fear, not analysis.

Don't let this battered growth setup go to waste.